A new Precision Health Economics-authored study on the societal value of CAR-T therapy is generating a significant level of interest within the scientific community. (more…)
MM&M editor-in-chief Marc Iskowitz quotes Precision’s Maureen Hennessey and cites new findings from Precision for Value’s Rapid Pulse survey in an article examining Otsuka’s new “digital drug” and the continued importance of adherence. (more…)
Precision for Value’s Jeremy Schafer discusses the impact of new and proposed state legislation on drug pricing with MedCity News. According to Schafer, new policies could present challenges for manufacturers in evolving their pricing strategies. (more…)
NEW ALIGNMENT OF INDUSTRY-LEADING CONSULTING AND DATA SERVICES PROVIDES UNIFIED HEALTH ECONOMICS AND OUTCOMES RESEARCH, PRICING, GLOBAL MARKET ACCESS, AND PAYER ANALYTICS TO SUPPORT PHARMACEUTICAL AND LIFE SCIENCES INNOVATORS
New York, NY – November 2, 2017 – Precision Value & Health today announced the formation of Precision Xtract—a new, focused alignment of the company’s global market access consulting and data services. The move is designed to offer clients an interconnected team of specialists developing strategies, tools, and tactics in support of next generation approaches to drug development and product value demonstration.
In the latest edition of Managed Healthcare Executive, Precision’s Ami Gopalan shares key insights from an exclusive Rapid Pulse survey. The findings shed light on how payers use nonpayer-generated data to make formulary decisions. (more…)
NPR describes the efforts of Precision Medicine Group cofounder Ethan Leder to deliver desperately needed medical and emergency supplies to Puerto Rico. (more…)
Precision Medicine Group cofounder Ethan Leder is featured in the Johns Hopkins University publication HUB, detailing his recent efforts to help personally deliver desperately needed medical and emergency supplies to Puerto Rico in the aftermath of Hurricane Maria. (more…)
ADDITION OF BERLIN-BASED LAB EXPANDS PRECISION’S LARGE ARRAY OF IMMUNE MONITORING CAPABILITIES AND BOLSTERS GLOBAL FOOTPRINT
Bethesda, MD and Berlin, Germany – October 4th, 2017 – Precision for Medicine, part of the Precision Medicine Group, announced today it has acquired Berlin-based Epiontis GmbH, a next-generation European specialty laboratory providing immune monitoring services through a novel, patent-protected epigenetic platform. The acquisition adds Epiontis’s unique epigenetic technology and expertise to Precision’s robust suite of immune monitoring services for clinical trials, bringing additional value and capabilities to clients. It expands Precision’s growing global footprint and further positions the company as a scientific frontrunner in the rapidly expanding precision medicine space.
Precision Value & Health President Dan Renick speaks with Ryan Black from Healthcare Analytics News, discussing the evolution of precision medicine and the importance of demonstrating value for new therapies to encourage reimbursement. (more…)
NEW ALIGNMENT OF INDUSTRY-LEADING SERVICES PROVIDES INTEGRATED SCIENCE, RESEARCH, TECHNOLOGY, ANALYTICS, AND COMMUNICATIONS TO INNOVATORS IN LIFE SCIENCES
Bethesda, MD – September 21, 2017 – Precision Medicine Group, a specialized services company supporting next generation approaches to drug development and commercialization, today announced the formation of Precision Value & Health—a focused set of complementary services working in concert to help pharmaceutical and life sciences clients establish the clinical, economic, and humanistic value of innovative therapies to payers, healthcare professionals, and patients.